Concourse Financial Group Securities’s Viracta Therapeutics, Inc. Common Stock VIRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Hold |
0
| – | – | – | 10291 |
|
|
2024
Q4 | – | Hold |
0
| – | – | – | 10301 |
|
|
2024
Q3 | – | Hold |
0
| – | – | – | 9941 |
|
|
2024
Q2 | – | Hold |
0
| – | – | – | 9597 |
|
|
2024
Q1 | – | Hold |
0
| – | – | – | 9371 |
|
|
2023
Q4 | – | Hold |
0
| – | – | – | 9149 |
|
|
2023
Q3 | – | Hold |
0
| – | – | – | 8919 |
|
|
2023
Q2 | – | Hold |
0
| – | – | – | 8706 |
|
|
2023
Q1 | – | Hold |
0
| – | – | – | 8374 |
|
|
2022
Q4 | – | Hold |
0
| – | – | – | 8382 |
|
|
2022
Q3 | – | Hold |
0
| – | – | – | 8201 |
|
|
2022
Q2 | – | Hold |
0
| – | – | – | 8054 |
|
|
2022
Q1 | – | Hold |
0
| – | – | – | 7868 |
|
|
2021
Q4 | – | Hold |
0
| – | – | – | 7704 |
|
|
2021
Q3 | – | Hold |
0
| – | – | – | 7408 |
|
|
2021
Q2 | – | Hold |
0
| – | – | – | 7119 |
|
|
2021
Q1 | – | Hold |
0
| – | – | – | 6845 |
|
|
2020
Q4 | – | Hold |
0
| – | – | – | 6617 |
|
|
2020
Q3 | – | Hold |
0
| – | – | – | 6391 |
|
|
2020
Q2 | – | Hold |
0
| – | – | – | 6237 |
|
|
2020
Q1 | – | Hold |
0
| – | – | – | 6144 |
|
|
2019
Q4 | – | Hold |
0
| – | – | – | 6056 |
|
|
2019
Q3 | – | Hold |
0
| – | – | – | 5907 |
|
|
2019
Q2 | – | Hold |
0
| – | – | – | 5914 |
|
|
2019
Q1 | – | Hold |
0
| – | – | – | 5808 |
|
|
2018
Q4 | – | Hold |
0
| – | – | – | 5720 |
|
|
2018
Q3 | – | Hold |
0
| – | – | – | 5568 |
|